Literature DB >> 7783650

Impaired nitric oxide release by glomeruli from diabetic rats.

P A Craven1, R K Studer, F R DeRubertis.   

Abstract

Basal nitric oxide (NO) production and NO responses to carbamylcholine (CCh) and the Ca2+ ionophore A23187 were measured with a NO electrode in glomeruli isolated from 2 to 3-month-diabetic versus age-matched control rats. In the presence of CCh or A23187, NO production was markedly reduced in glomeruli from diabetic versus control rats. Spontaneous generation of NO by s-nitrosopenicillamine (SNAP) was also reduced in the presence of glomeruli from diabetic rats as compared with values either in control glomeruli or in buffer alone. The results demonstrate an impairment of NO generation and/or stability in glomeruli from 2 to 3-month-diabetic rats, which correlates with the previously observed suppression of NO-dependent glomerular cyclic guanosine 3',5'-monophosphate (cGMP) induced by diabetes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783650     DOI: 10.1016/0026-0495(95)90178-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.

Authors:  X L Du; D Edelstein; S Dimmeler; Q Ju; C Sui; M Brownlee
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Yoshihiro Kuno; Masayuki Iyoda; Takanori Shibata; Yuki Hirai; Tadao Akizawa
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 4.  Pathogenic role of nitric oxide alterations in diabetic nephropathy.

Authors:  Sharma S Prabhakar
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

5.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.

Authors:  Yukiko Kanetsuna; Keiko Takahashi; Michio Nagata; Maureen A Gannon; Matthew D Breyer; Raymond C Harris; Takamune Takahashi
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

6.  Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.

Authors:  K C Choi; S C Lee; S W Kim; N H Kim; J U Lee; Y J Kang
Journal:  Korean J Intern Med       Date:  1999-01       Impact factor: 2.884

Review 7.  Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.

Authors:  Takamune Takahashi; Raymond C Harris
Journal:  J Diabetes Res       Date:  2014-10-13       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.